US20050113855A1 - Surgical implant - Google Patents
Surgical implant Download PDFInfo
- Publication number
- US20050113855A1 US20050113855A1 US10/915,626 US91562604A US2005113855A1 US 20050113855 A1 US20050113855 A1 US 20050113855A1 US 91562604 A US91562604 A US 91562604A US 2005113855 A1 US2005113855 A1 US 2005113855A1
- Authority
- US
- United States
- Prior art keywords
- medical device
- implant
- implant body
- penetrating member
- penetrating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12104—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in an air passage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12163—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a string of elements connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3468—Trocars; Puncturing needles for implanting or removing devices, e.g. prostheses, implants, seeds, wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
- A61F2/0031—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
- A61F2/0036—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0069—Devices for implanting pellets, e.g. markers or solid medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
- A61B17/06166—Sutures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00004—(bio)absorbable, (bio)resorbable, resorptive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00526—Methods of manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0069—Implantable devices or invasive measures in the wall of the stomach
Definitions
- This invention relates to medical devices, and more particularly, to surgical implants.
- GERD Gastroesophageal Reflux Disease
- GERD is a pathophysiologic condition of the esophagus in which gastric fluids escape from the stomach and travel into the esophagus.
- the symptoms of GERD can include heartburn, regurgitation of gastric contents, or dysphagia, which is a difficulty in swallowing or moving swallowed material into the stomach.
- GERD often results from, among other things, transient lower esophageal sphincter (hereinafter “LES”) relaxations and decreased LES resting tone.
- LES transient lower esophageal sphincter
- One endoscopic procedure used to treat GERD involves transmurally inserting one or more implants into preformed incisions in the LES, and particularly into the submucosal tissue layer, as described in U.S. Pat. No. 6,098,629 to Johnson et al., which is fully incorporated herein by reference.
- the implants effectively treat GERD by increasing the mass of the LES, thus improving the LES resting tone.
- the procedure involves first endoscopically identifying an insertion site to access the submucosa adjacent the LES. The layer of mucosa that covers the submucosa is then pierced by a sharp dissection tool. Next, a pouch sized to receive the prosthesis is created in the submucosa.
- the pouch can be created by liquid infusion (i.e., by forming a blister) or by blunt dissection using a blunt tool.
- the implant is inserted into the pouch.
- the implant is typically inserted by a grasper, a clamshell deployment device, or another similar insertion tool. After insertion, the mucosal opening is closed by using an appropriate conventional closing technique.
- Soft tissue implants can also be used for brachytherapy. Brachytherapy involves inserting a radioactive implant directly into or adjacent a tumor to effect remission of the tumor. Similarly, soft tissue implants can be used to deliver various drugs to a target location. That is, once an implant impregnated or coated with a drug is implanted in a patient's soft tissue, the implant releases the drug into the patient.
- Implants migrate when, for example, the pouch created to accommodate the implant is too large for the implant. In this situation, the implant can be displaced from its target position into a less ideal position. In more serious cases, implant migration renders the implant entirely ineffective, thus requiring follow-up or additional medical procedures.
- Another drawback is the size of presently available implants. Often times a single implant is simply too small to achieve the desired bulk in the target area. Thus, the insertion of multiple implants in the target area is often required. Delivering multiple implants, however, can require that a physician reinsert the delivery tool into a target tissue for each implant, thus increasing the time required for the procedure and causing unnecessary trauma.
- the foregoing object of the present invention is obtained by providing a linked implant having two or more bio-remodelable implant bodies disposed along a length of string.
- the implant bodies can be formed of an extra-cellular matrix material, such as small intestine submucosa, and can be shaped as desired for a given application.
- the implant bodies can be spherical, ellipsoid, cuboid, or cylindrical in shape.
- radiopaque markers can be provided to assist in visualization of the device during delivery within a patient.
- the foregoing object is obtained by providing a linked implant that forms a net or matrix.
- methods are provided for assembling a linked implant.
- a tipped implant including an implant body having a first outside periphery, and a penetrating member connected to the implant body.
- the penetrating member can be formed from a biocompatible material such as stainless steel, plastic, or even a rigid bio-resorbable material.
- the penetrating member includes a penetrating portion and an expanding portion located adjacent to the penetrating portion.
- the penetrating portion can form a leading edge or a leading point.
- the expansion portion expands the opening created by the penetrating portion to a diameter that is sufficiently large to receive the implant.
- a passageway that extends axially through the implant body and/or the penetrating member can be provided.
- the passageway permits the tipped implant to be directed over a guidewire to the target site.
- a method for assembling a tipped implant.
- a method is provided for simultaneously creating an opening sized to receive an implant and inserting the implant into the opening.
- FIG. 1 is a side view of one embodiment of the present invention including several cylindrical implant bodies and a string;
- FIG. 2 is a side view of one embodiment of the present invention including several ellipsoid implant bodies and a string;
- FIG. 3 is a side view of one embodiment of the present invention including several spherical implant bodies and a string;
- FIG. 4 is a side view of one embodiment of the present invention including a bulking net
- FIG. 5 is a cross-sectional side view of one embodiment of the present invention including radiopaque markers
- FIG. 6 is a cross-sectional side view of one embodiment of the present invention including an assembly mold
- FIG. 7-12 sequentially illustrate a method of inserting a linked surgical implant according to one embodiment of the present invention
- FIG. 13 is a cross-sectional side view of one embodiment of the present invention including a guidewire lumen
- FIG. 14 is a cross-sectional side view of one embodiment of the present invention including an assembly tube
- FIG. 15 is a perspective side view of one embodiment of the present invention including an implant and an implant tip;
- FIG. 16 is a perspective side view of one embodiment of the present invention including an implant, an implant tip, a channel, and a guidewire;
- FIG. 17 is a cross-sectional side view of one embodiment of the present invention including an implant, and an implant tip;
- FIG. 18 is a cross-sectional side view of one embodiment of the present invention including an implant, an implant tip, and a channel;
- FIG. 19 is a cross-sectional side view of one embodiment of the present invention including an assembly mold.
- FIGS. 20-26 sequentially illustrate one embodiment of the method according to the present invention to implant a medical device having an implant with an implant tip.
- FIG. 1 illustrates a first embodiment of the present invention, and particularly, linked implant 10 .
- linked implant 10 normally comprises two or more implant bodies 14 attached to a string 18 .
- linked implant 10 is delivered to a location adjacent the target tissue (e.g., the esophageal lumen, superior to the LES).
- Linked implant 10 is then introduced into the target tissue, thereby bulking the surrounding tissue.
- Implant body 14 can be formed of a variety of desirable, biocompatible implant materials suitable for bulking and supporting a target tissue.
- the implant body is formed of a bio-remodelable, extra-cellular matrix.
- One suitable form of extra-cellular matrix is harvested from porcine or bovine small intestine submucosa (hereinafter “SIS”).
- SIS is a preferred material because it has special bio-remodeling characteristics. Because of these characteristics, SIS has been used successfully in various surgical applications. One such application is described in U.S. Pat. No. 6,358,284 to Fearnot et al., which is incorporated herein by reference. That surgical application involves the application of purified submucosa as a ureter graft.
- the implant body can be formed from a variety of other bio-compatible materials, including for example, stainless steel, polymers, and biocompatible foams such as silicone foam or polyurethane foam.
- the implant bodies 14 can be provided in a wide variety of shapes.
- implant bodies 14 can be formed into cylindrical bodies ( FIG. 1 ), ellipsoid bodies ( FIG. 2 ) or spherical bodies ( FIGS. 3 and 4 ).
- the size of each implant body can vary depending on the particular medical application for the linked implant.
- the implant body also can be impregnated or covered with a drug suitable for causing the desired therapeutic outcome.
- a biocompatible, radio-opaque powder, ball, or other marker for example stainless steel ball 34
- a physician can track the position of the implant body relative to the surrounding anatomy and/or the target tissue, thereby facilitating proper placement of the linked implant within the patient.
- the physician can track the position of the implant body fluoroscopically during the delivery of the linked implant.
- linked implant 10 includes a string 18 that is used to link two or more implant bodies 14 .
- string 18 secures and stabilizes implant bodies 14 .
- string 18 prevents implant bodies 14 from individually migrating into an undesired or ineffective position.
- String 18 can be a biocompatible mono-filament or thread.
- One preferred material is the thread or filament utilized in resorbable sutures. Alternatively, non-resorbable sutures can be used.
- implant bodies 14 can be disposed closely together, as shown in FIG. 2 , or spread apart from each other, as shown in FIGS. 1, 3 , and 4 . That is, the separation between implant bodies can be tailored to a particular desired position along the string or filament. Further, the implant bodies need not be disposed along the string equidistantly. Rather, the distances between adjacent implant bodies can by varied as desired. Moreover, as illustrated in FIG. 4 , implant bodies 14 can be disposed on a net of filaments. Such a physician to extend the implants laterally and longitudinally relative to a wound or surgical site, thus reinforcing and bulking the wound or surgical site.
- Mold 26 is configured to form cylindrical implant bodies 14 .
- a mold capable of forming spherical, cuboid, and/or elliptical implant bodies could alternatively be used. While illustrative mold 26 is configured to form a linked implant 10 having ten (10) implant bodies 14 , molds capable of forming a linked implant with additional or fewer implant bodies could be used.
- Linked implant 10 is assembled as illustrated in FIG. 6 .
- a string 18 is threaded through cylindrical forms 30 .
- the desired implant material is packed into each cylindrical form 30 .
- the implant material comprises a liquid that is injected into the form.
- a radio-opaque marker 34 can be optionally inserted into the cylinder.
- linked implants formed of epoxy materials are cured through polymerization or cross-linking reactions
- linked implants formed of cement materials are cured through hydrolysis reactions.
- Additional exemplary methods of forming a linked implant include insert molding, wherein a plastic can be injected into a molding and an additional object can be inserted into the plastic.
- FIG. 14 illustrates a tubular mold used to assemble implant bodies 14 and string 18 .
- the desired implant material is packed into tubular mold 44 .
- the linked implant can be air-dried or freeze-dried, preferably overnight.
- the dried, linked implant 10 can then be removed from tubular mold 44 and cut to a desired length with a scalpel or scissors.
- Linked implant 10 can be used for a wide variety of applications, including minimally invasive or open surgical applications.
- An exemplary minimally invasive procedure is the treatment of GERD by bulking the LES.
- a preferred method of delivering the linked implant generally includes first identifying the desired implant location with an endoscope and then inserting the linked implant into that location.
- an illustrative endoscope 74 (which is preferably an X-Ray fluoroscope, ultrasound endoscope, or conventional endoscope) is passed through the mouth and esophagus 70 of a patient and delivered to the vicinity of LES 82 , superior to the stomach 84 and adjacent to diaphragm 78 .
- a needle 86 is passed through the working channel of endoscope 74 and into the LES 82 , as shown in FIG. 8 .
- guidewire 90 is inserted to maintain access to the target tissue. Needle 86 is withdrawn, while guidewire 90 remains in the target tissue, as illustrated in FIG. 10 .
- catheter 94 is inserted over the guidewire and into the desired implant location to deliver linked implant 10 , as shown in FIG. 11 .
- Linked implant 10 can be pushed into the LES by a conventional pusher tool inserted through the lumen of the catheter 94 ( FIG. 11 ) into the desired implant location.
- the position of catheter 94 can be changed to distribute additional implant bodies 14 throughout the target tissue area.
- the linked implant can alternatively be configured for delivery directly over a guidewire.
- the implant body 14 is provided with a passageway 60 , which is adapted to receive a guidewire.
- a plurality of implant bodies 14 are back-loaded onto a guidewire. Once the implant bodies are loaded, the distal end of the guidewire can be inserted into the target tissue, as shown in FIG. 10 .
- a conventional pusher tool (not shown) is then used to push the implant bodies into the target tissue.
- the linked implant can alternatively be delivered without the use of a guidewire.
- the linked implant can be delivered into a target tissue through a catheter inserted directly into the LES.
- a cannula can be used to deliver the linked implant.
- Linked implant 10 can alternatively be used in various open surgical procedures in which tissue bulking or reinforcement is necessary.
- Linked implant 10 can be directly inserted into an incision by a physician.
- the physician can tailor the linked implant 14 for the particular incision by, for example, using several separate linked implants, joining two or more linked implants to increase overall implant length, or cutting a linked implant to reduce its overall length.
- a physician can insert a net of interconnected linked implants (see FIG. 4 ). Indeed, a physician can wad or bundle the net of interconnected linked implants and insert the wadded or bundled net into an incision.
- a net configuration can be particularly useful where a physician desires to reinforce or bulk a large incision.
- FIGS. 15 and 16 illustrate a second embodiment of the present invention, and particularly, tipped implant 110 .
- tipped implant 110 generally comprises implant body 126 (often having a rough or non-uniform edge), and a smooth implant tip 114 having a penetrating portion and an expanding portion.
- tip 114 also includes a proximal end having shank 132 with threads 134 .
- shank 132 secures implant body 126 to tip 114 .
- tipped implant 110 is delivered to a location adjacent the target tissue (e.g., the esophageal lumen, superior to the LES) through the working channel of an endoscope.
- Tip 114 is then introduced into the target tissue such that the penetrating portion of the tip punctures the target tissue.
- the expansion portion of the tip widens the puncture created by the penetrating portion, thus forming a cavity sized to receive the tipped implant.
- the shape of the tip is preferably configured to control or guide the orientation and trajectory of the implant body as the tip penetrates and enters the target tissue. That is, the tip can be configured to dilate the target tissue as necessary to achieve a desired orientation and trajectory for the implant body.
- the tip can be curved, thereby guiding the implant body over a curved trajectory as the implant body enters the target tissue.
- the tip can be formed to simply puncture and/or dilate a target tissue.
- tip 114 comprises a distal end having a penetrating portion or point 118 .
- the leading point of the tip is preferably sharp so as to easily pierce or puncture the target tissue while avoiding unnecessary trauma to adjacent tissues.
- the penetrating portion can be formed into a variety of shapes configured to penetrate, cut, tear, stretch, or otherwise dilate the target tissue.
- the penetrating portion can be provided with a cutting edge to further facilitate penetration of the tipped implant into a target tissue.
- a wedge-shaped tip having a sharpened leading edge can be used.
- tip 114 has a round cross-section.
- other shapes having different cross-sections can alternatively be used.
- the tip can be triangular, square, elliptical, or otherwise asymmetrical in cross section.
- the tip can be formed of a variety of materials that are sufficiently rigid to penetrate the target tissue.
- the tip can be formed of metals, ceramics, polymers, composites, natural materials, bio-resorbable materials, or dissolvable materials.
- the implant tip is formed from surgical grade stainless steel.
- tip 114 also includes an expanding portion 122 .
- Expanding portion 122 is adapted to enlarge the puncture the incision initially created by point 118 to a shape that closely approximates the projected shape of the tipped implant. As shown in FIGS. 15 and 17 , expanding portion 122 is funnel-shaped so as to reduce trauma to the dilated tissue. Additionally, as illustrated in FIG. 15 , the maximum circumference of expanding portion 122 is preferably about the same size as or slightly larger than implant body 126 . This ensures that the opening created by the tip is large enough so that the implant body does not catch or snag on the tissue surrounding the opening.
- the expanding portion can be configured to expand the opening created by point 118 to a circumference that is significantly larger than the circumference of the implant body.
- the expanding portion of the tip can also be configured to resist migration of the tipped implant 110 in an undesirable direction. This can be accomplished by the addition of an arrow-shaped or lanciform expanding portion that readily penetrates and expands the target tissue as the tipped implant is moved in a first direction, yet resists movement in a second direction opposite the first direction.
- Tip 114 further includes shank 132 , as illustrated in FIG. 17 .
- Shank 132 is located at the proximal end of tip 114 , and is adapted to secure tip 114 to implant body 126 .
- threads 134 are provided as a gripping surface to securely fasten implant body 126 to tip 114 .
- Implant body 126 is fastened to shank 132 and abuts the proximal end of the tip, as described in detail below.
- medical device 110 is provided with passageway 138 .
- Passageway 138 extends axially through both tip 114 and implant body 126 .
- Passageway 138 is adapted to slide over a guidewire, needle, or a cannula.
- the tip of the tipped implant 110 can therefore be inserted into the target tissue with the proper orientation relative to the target tissue.
- passageway 138 facilitates insertion of tipped implant 110 .
- the target tissue can easily be pierced and infused with a desired fluid before insertion of the medical device.
- the third embodiment of the tipped implant 110 is the same as the second embodiment described above.
- the implant body 126 can be formed of a variety of desirable implant materials, such as those discussed with respect to the implant bodies of the first embodiment.
- the implant body is formed of purified submucosa, which is a bio-remodelable material that can be derived from, among other things, the small intestine submucosa of vertebrates.
- a biocompatible, radio-opaque powder or other marker can also be added to the implant body. This facilitates proper placement of the tipped implant within the patient.
- a variety of methods can be employed to assemble tipped implant 110 .
- a preferred method of assembly includes securing the distal end of the tip, either manually or by a clamp.
- a rod is then inserted through the tip passageway.
- Thin strips of SIS are coiled around the shank and the rod as necessary to create an implant body having a desired diameter.
- the tipped implant is assembled, it is dried.
- the tipped implant can be air-dried or freeze-dried, preferably overnight.
- the dried implant body can then be cut to a desired size with a scalpel.
- FIG. 19 Another method of assembly is illustrated in FIG. 19 and involves tamping strips of SIS material into a mold that grips the implant tip.
- a rod 146 is first inserted through tip 114 .
- An end of a strip of SIS material is then temporarily pinned to shank 132 (for example, by pressing the end of the strip to shank 132 ) and the remainder of the strip of SIS is loosely wrapped around shank 132 and a proximal portion of rod 146 .
- Tip 114 is thereafter inserted into mold 142 far enough so that tip 114 engages and is retained by edge 158 of mold 142 .
- packing rod 154 is used to tamp the strip, or strips, of SIS to shank 132 .
- the tip and strip of SIS is then dried in the mold, as described above with respect to the manually assembled implant.
- pusher rod 150 is used to remove the assembled implant body and tip from mold 142 .
- additional strips of SIS can be added to the tip by repeating the same process. Notably, drying the implant in the mold results in a smooth, low-profile implant that can be implanted more smoothly.
- a preferred method of delivering the tipped implant generally includes first identifying the desired implant location with an endoscope and then inserting the tipped implant into that location.
- endoscope 74 is passed through the mouth and esophagus 70 of a patient and delivered to the vicinity of LES 82 .
- a needle 86 is passed through the working channel of endoscope 74 , as shown in FIG. 21 .
- guidewire 90 is used to maintain access to the target tissue ( FIG. 22 ).
- Guidewire 90 ultimately serves as a pilot for the delivery of the tipped implant into a precise location.
- needle 86 is removed ( FIG. 23 ).
- the tipped implant 110 is subsequently threaded over guidewire 90 ( FIG. 24 ).
- the tipped implant is then pushed along guidewire 90 toward the desired implant location.
- the tipped implant is pushed into the target tissue by conventional pusher tool 94 .
- guidewire 90 is withdrawn (see FIG. 25 ).
- this procedure may be repeated to insert as many tipped implants 110 as necessary for a given medical condition.
- an ultrasound endoscope can be used to identify the target area and serve as a working channel for the delivery of the tipped implant.
- the tipped implant can alternatively be delivered without the use of a guidewire.
- the tipped implant can be delivered into a target tissue through a cannula or catheter, or over a needle by using a conventional pusher instrument.
Abstract
An implant is disclosed including a bio-compatible implant body that can be provided with a tip, or interconnected by one or more filaments. The implant body can be formed of a variety of biocompatible materials, including bio-remodelable materials such as small intestine submucosa. Methods are disclosed for assembly of the implant. Additionally, a method is disclosed for delivering the implant to a desired location in a patient.
Description
- This claims the benefit of U.S. Provisional Application Ser. No. 60/494,613, entitled “Tipped Implant,” filed on Aug. 11, 2003, and U.S. Provisional Application Ser. No. 60/558,163, entitled “Surgical Graft,” filed on Mar. 30, 2004.
- This invention relates to medical devices, and more particularly, to surgical implants.
- Many surgical or endoscopic applications require the insertion of an implant into an incision in a patient's soft tissue. For example, such implants can be used to add bulk to a target tissue, thereby reinforcing the target tissue area. These procedures are often referred to as “bulking” procedures, and are frequently used in treating urological diseases, including urinary incontinence and vesicourethral reflux disease. “Bulking” procedures are also often used to treat Gastroesophageal Reflux Disease (hereinafter “GERD”). GERD is a form of dyspepsia that afflicts approximately 40% of adults in the United States. More specifically, GERD is a pathophysiologic condition of the esophagus in which gastric fluids escape from the stomach and travel into the esophagus. The symptoms of GERD can include heartburn, regurgitation of gastric contents, or dysphagia, which is a difficulty in swallowing or moving swallowed material into the stomach. GERD often results from, among other things, transient lower esophageal sphincter (hereinafter “LES”) relaxations and decreased LES resting tone.
- One endoscopic procedure used to treat GERD involves transmurally inserting one or more implants into preformed incisions in the LES, and particularly into the submucosal tissue layer, as described in U.S. Pat. No. 6,098,629 to Johnson et al., which is fully incorporated herein by reference. In general, the implants effectively treat GERD by increasing the mass of the LES, thus improving the LES resting tone. The procedure involves first endoscopically identifying an insertion site to access the submucosa adjacent the LES. The layer of mucosa that covers the submucosa is then pierced by a sharp dissection tool. Next, a pouch sized to receive the prosthesis is created in the submucosa. The pouch can be created by liquid infusion (i.e., by forming a blister) or by blunt dissection using a blunt tool. Once the pouch is created, the implant is inserted into the pouch. The implant is typically inserted by a grasper, a clamshell deployment device, or another similar insertion tool. After insertion, the mucosal opening is closed by using an appropriate conventional closing technique.
- Soft tissue implants can also be used for brachytherapy. Brachytherapy involves inserting a radioactive implant directly into or adjacent a tumor to effect remission of the tumor. Similarly, soft tissue implants can be used to deliver various drugs to a target location. That is, once an implant impregnated or coated with a drug is implanted in a patient's soft tissue, the implant releases the drug into the patient.
- However, presently available procedures for inserting an implant have several significant drawbacks, including implant migration. Implants migrate when, for example, the pouch created to accommodate the implant is too large for the implant. In this situation, the implant can be displaced from its target position into a less ideal position. In more serious cases, implant migration renders the implant entirely ineffective, thus requiring follow-up or additional medical procedures.
- Another drawback is the size of presently available implants. Often times a single implant is simply too small to achieve the desired bulk in the target area. Thus, the insertion of multiple implants in the target area is often required. Delivering multiple implants, however, can require that a physician reinsert the delivery tool into a target tissue for each implant, thus increasing the time required for the procedure and causing unnecessary trauma.
- Presently available procedures for transmurally inserting an implant, for example, into the LES, have several additional drawbacks. First, creating a pouch for the implant typically causes excessive trauma to the surrounding tissues, especially if a blunt tool is used to create the pouch. Another drawback is that insertion of an implant into the target tissue can be difficult because the implant can catch or snag on the edges of the mucosal incision. Moreover, implants can be difficult to deliver into a target tissue along a desired trajectory and in a desired spatial orientation.
- Accordingly, it is an object of the present invention to provide a medical device having features that resolve or improve upon one or more of the above-described drawbacks.
- According to a first aspect of the present invention, the foregoing object of the present invention is obtained by providing a linked implant having two or more bio-remodelable implant bodies disposed along a length of string. The implant bodies can be formed of an extra-cellular matrix material, such as small intestine submucosa, and can be shaped as desired for a given application. For example, the implant bodies can be spherical, ellipsoid, cuboid, or cylindrical in shape. Additionally, radiopaque markers can be provided to assist in visualization of the device during delivery within a patient. According to another aspect of the present invention, the foregoing object is obtained by providing a linked implant that forms a net or matrix. According to yet another aspect of the present invention, methods are provided for assembling a linked implant.
- According to yet another aspect of the present invention, the foregoing object of the present invention is obtained by providing a tipped implant including an implant body having a first outside periphery, and a penetrating member connected to the implant body. The penetrating member can be formed from a biocompatible material such as stainless steel, plastic, or even a rigid bio-resorbable material. The penetrating member includes a penetrating portion and an expanding portion located adjacent to the penetrating portion. The penetrating portion can form a leading edge or a leading point. The expansion portion expands the opening created by the penetrating portion to a diameter that is sufficiently large to receive the implant.
- According to another aspect of the present invention, a passageway that extends axially through the implant body and/or the penetrating member can be provided. The passageway permits the tipped implant to be directed over a guidewire to the target site.
- According to another aspect of the present invention, a method is provided for assembling a tipped implant. According to yet another aspect of the invention, a method is provided for simultaneously creating an opening sized to receive an implant and inserting the implant into the opening.
-
FIG. 1 is a side view of one embodiment of the present invention including several cylindrical implant bodies and a string; -
FIG. 2 is a side view of one embodiment of the present invention including several ellipsoid implant bodies and a string; -
FIG. 3 is a side view of one embodiment of the present invention including several spherical implant bodies and a string; -
FIG. 4 is a side view of one embodiment of the present invention including a bulking net; -
FIG. 5 is a cross-sectional side view of one embodiment of the present invention including radiopaque markers; -
FIG. 6 is a cross-sectional side view of one embodiment of the present invention including an assembly mold; -
FIG. 7-12 sequentially illustrate a method of inserting a linked surgical implant according to one embodiment of the present invention; -
FIG. 13 is a cross-sectional side view of one embodiment of the present invention including a guidewire lumen; -
FIG. 14 is a cross-sectional side view of one embodiment of the present invention including an assembly tube; -
FIG. 15 is a perspective side view of one embodiment of the present invention including an implant and an implant tip; -
FIG. 16 is a perspective side view of one embodiment of the present invention including an implant, an implant tip, a channel, and a guidewire; -
FIG. 17 is a cross-sectional side view of one embodiment of the present invention including an implant, and an implant tip; -
FIG. 18 is a cross-sectional side view of one embodiment of the present invention including an implant, an implant tip, and a channel; -
FIG. 19 is a cross-sectional side view of one embodiment of the present invention including an assembly mold; and -
FIGS. 20-26 sequentially illustrate one embodiment of the method according to the present invention to implant a medical device having an implant with an implant tip. - The invention is described with reference to the drawings in which like elements are referred to by like numerals. The relationship and functioning of the various elements of this invention are better understood by the following detailed description. However, the embodiments of this invention as described below are by way of example only, and the invention is not limited to the embodiments illustrated in the drawings. It should also be understood that the drawings are not to scale and in certain instances, details which are not necessary for an understanding of the present invention, such as conventional details of fabrication and assembly, have been omitted.
- Referring to the drawings,
FIG. 1 illustrates a first embodiment of the present invention, and particularly, linkedimplant 10. As illustrated inFIGS. 1-4 , linkedimplant 10 normally comprises two ormore implant bodies 14 attached to astring 18. In general, linkedimplant 10 is delivered to a location adjacent the target tissue (e.g., the esophageal lumen, superior to the LES). Linkedimplant 10 is then introduced into the target tissue, thereby bulking the surrounding tissue. -
Implant body 14 can be formed of a variety of desirable, biocompatible implant materials suitable for bulking and supporting a target tissue. In a preferred embodiment of the present invention, the implant body is formed of a bio-remodelable, extra-cellular matrix. One suitable form of extra-cellular matrix is harvested from porcine or bovine small intestine submucosa (hereinafter “SIS”). SIS is a preferred material because it has special bio-remodeling characteristics. Because of these characteristics, SIS has been used successfully in various surgical applications. One such application is described in U.S. Pat. No. 6,358,284 to Fearnot et al., which is incorporated herein by reference. That surgical application involves the application of purified submucosa as a ureter graft. As an alternative to using a bio-remodelable material such as SIS, the implant body can be formed from a variety of other bio-compatible materials, including for example, stainless steel, polymers, and biocompatible foams such as silicone foam or polyurethane foam. - As shown in
FIGS. 1-4 , theimplant bodies 14 can be provided in a wide variety of shapes. For example,implant bodies 14 can be formed into cylindrical bodies (FIG. 1 ), ellipsoid bodies (FIG. 2 ) or spherical bodies (FIGS. 3 and 4 ). Likewise, the size of each implant body can vary depending on the particular medical application for the linked implant. Moreover, depending on the therapeutic needs of a patient, e.g., treatment of a tumor, the implant body also can be impregnated or covered with a drug suitable for causing the desired therapeutic outcome. - As shown in
FIG. 5 , a biocompatible, radio-opaque powder, ball, or other marker, for examplestainless steel ball 34, can also be added to the implant body. As a result, a physician can track the position of the implant body relative to the surrounding anatomy and/or the target tissue, thereby facilitating proper placement of the linked implant within the patient. For example, the physician can track the position of the implant body fluoroscopically during the delivery of the linked implant. - As illustrated in
FIGS. 1-5 , linkedimplant 10 includes astring 18 that is used to link two ormore implant bodies 14. Once properly placed in a target tissue,string 18 secures and stabilizesimplant bodies 14. In particular,string 18 preventsimplant bodies 14 from individually migrating into an undesired or ineffective position.String 18 can be a biocompatible mono-filament or thread. One preferred material is the thread or filament utilized in resorbable sutures. Alternatively, non-resorbable sutures can be used. - It should also be noted that
implant bodies 14 can be disposed closely together, as shown inFIG. 2 , or spread apart from each other, as shown inFIGS. 1, 3 , and 4. That is, the separation between implant bodies can be tailored to a particular desired position along the string or filament. Further, the implant bodies need not be disposed along the string equidistantly. Rather, the distances between adjacent implant bodies can by varied as desired. Moreover, as illustrated inFIG. 4 ,implant bodies 14 can be disposed on a net of filaments. Such a net arrangement allows a physician to extend the implants laterally and longitudinally relative to a wound or surgical site, thus reinforcing and bulking the wound or surgical site. - A variety of methods can be employed to assemble linked
implant 10. A preferred method of assembly is illustrated inFIG. 6 .Mold 26 is configured to formcylindrical implant bodies 14. A mold capable of forming spherical, cuboid, and/or elliptical implant bodies could alternatively be used. Whileillustrative mold 26 is configured to form a linkedimplant 10 having ten (10)implant bodies 14, molds capable of forming a linked implant with additional or fewer implant bodies could be used. - Linked
implant 10 is assembled as illustrated inFIG. 6 . First, astring 18 is threaded throughcylindrical forms 30. Afterstring 18 is in place, the desired implant material is packed into eachcylindrical form 30. In one method, the implant material comprises a liquid that is injected into the form. Beforecylindrical form 30 has been completely filled with the implant material, such as SIS, a radio-opaque marker 34 can be optionally inserted into the cylinder. Once the linked implant is assembled, it is dried. The linked implant can be air-dried or freeze-dried, preferably overnight. The dried, linked implant can then be removed frommold 26 and cut to a desired length with a scalpel or scissors. It should be noted that alternative curing methods can be used for various materials. For example, linked implants formed of epoxy materials are cured through polymerization or cross-linking reactions, and linked implants formed of cement materials are cured through hydrolysis reactions. Additional exemplary methods of forming a linked implant include insert molding, wherein a plastic can be injected into a molding and an additional object can be inserted into the plastic. - Linked
implant 10 can also be assembled as illustrated inFIG. 14 .FIG. 14 illustrates a tubular mold used to assembleimplant bodies 14 andstring 18. To assemble linkedimplant 10, the desired implant material is packed intotubular mold 44. The linked implant can be air-dried or freeze-dried, preferably overnight. The dried, linkedimplant 10 can then be removed fromtubular mold 44 and cut to a desired length with a scalpel or scissors. - Linked
implant 10 can be used for a wide variety of applications, including minimally invasive or open surgical applications. An exemplary minimally invasive procedure is the treatment of GERD by bulking the LES. For applications involving GERD, a preferred method of delivering the linked implant generally includes first identifying the desired implant location with an endoscope and then inserting the linked implant into that location. Referring toFIG. 7 , an illustrative endoscope 74 (which is preferably an X-Ray fluoroscope, ultrasound endoscope, or conventional endoscope) is passed through the mouth andesophagus 70 of a patient and delivered to the vicinity ofLES 82, superior to thestomach 84 and adjacent to diaphragm 78. Aneedle 86 is passed through the working channel ofendoscope 74 and into theLES 82, as shown inFIG. 8 . As illustrated inFIG. 9 , onceneedle 86 is in theLES 82, guidewire 90 is inserted to maintain access to the target tissue.Needle 86 is withdrawn, whileguidewire 90 remains in the target tissue, as illustrated inFIG. 10 . Subsequently,catheter 94 is inserted over the guidewire and into the desired implant location to deliver linkedimplant 10, as shown inFIG. 11 . Linkedimplant 10 can be pushed into the LES by a conventional pusher tool inserted through the lumen of the catheter 94 (FIG. 11 ) into the desired implant location. As illustrated inFIG. 11 , throughout the delivery of the linked implant, the position ofcatheter 94 can be changed to distributeadditional implant bodies 14 throughout the target tissue area. Once the linked implant is in the target tissue,catheter 94 andendoscope 74 are withdrawn, as illustrated inFIG. 12 . - As shown in
FIG. 13 , the linked implant can alternatively be configured for delivery directly over a guidewire. In this delivery configuration, theimplant body 14 is provided with apassageway 60, which is adapted to receive a guidewire. Before delivery, a plurality ofimplant bodies 14 are back-loaded onto a guidewire. Once the implant bodies are loaded, the distal end of the guidewire can be inserted into the target tissue, as shown inFIG. 10 . A conventional pusher tool (not shown) is then used to push the implant bodies into the target tissue. - It should also be noted that the linked implant can alternatively be delivered without the use of a guidewire. For example, the linked implant can be delivered into a target tissue through a catheter inserted directly into the LES. In another alternative, a cannula can be used to deliver the linked implant.
- Linked
implant 10 can alternatively be used in various open surgical procedures in which tissue bulking or reinforcement is necessary. Linkedimplant 10 can be directly inserted into an incision by a physician. In either open or minimally invasive procedures, the physician can tailor the linkedimplant 14 for the particular incision by, for example, using several separate linked implants, joining two or more linked implants to increase overall implant length, or cutting a linked implant to reduce its overall length. Alternatively, a physician can insert a net of interconnected linked implants (seeFIG. 4 ). Indeed, a physician can wad or bundle the net of interconnected linked implants and insert the wadded or bundled net into an incision. A net configuration can be particularly useful where a physician desires to reinforce or bulk a large incision. - Referring to the drawings,
FIGS. 15 and 16 illustrate a second embodiment of the present invention, and particularly, tippedimplant 110. As best seen inFIG. 15 , tippedimplant 110 generally comprises implant body 126 (often having a rough or non-uniform edge), and asmooth implant tip 114 having a penetrating portion and an expanding portion. As illustrated inFIG. 17 ,tip 114 also includes a proximalend having shank 132 withthreads 134. As discussed in greater detail below,shank 132 securesimplant body 126 to tip 114. - In general, tipped
implant 110 is delivered to a location adjacent the target tissue (e.g., the esophageal lumen, superior to the LES) through the working channel of an endoscope.Tip 114 is then introduced into the target tissue such that the penetrating portion of the tip punctures the target tissue. As the tip is advanced into the target tissue, the expansion portion of the tip widens the puncture created by the penetrating portion, thus forming a cavity sized to receive the tipped implant. Additionally, the shape of the tip is preferably configured to control or guide the orientation and trajectory of the implant body as the tip penetrates and enters the target tissue. That is, the tip can be configured to dilate the target tissue as necessary to achieve a desired orientation and trajectory for the implant body. For example, the tip can be curved, thereby guiding the implant body over a curved trajectory as the implant body enters the target tissue. Alternatively, the tip can be formed to simply puncture and/or dilate a target tissue. - As best illustrated in
FIG. 15 ,tip 114 comprises a distal end having a penetrating portion orpoint 118. The leading point of the tip is preferably sharp so as to easily pierce or puncture the target tissue while avoiding unnecessary trauma to adjacent tissues. Of course, in alternative embodiments of the present invention, the penetrating portion can be formed into a variety of shapes configured to penetrate, cut, tear, stretch, or otherwise dilate the target tissue. Alternatively, the penetrating portion can be provided with a cutting edge to further facilitate penetration of the tipped implant into a target tissue. For example, a wedge-shaped tip having a sharpened leading edge can be used. As illustrated inFIG. 15 ,tip 114 has a round cross-section. However, other shapes having different cross-sections can alternatively be used. For example, the tip can be triangular, square, elliptical, or otherwise asymmetrical in cross section. - The tip can be formed of a variety of materials that are sufficiently rigid to penetrate the target tissue. For example, the tip can be formed of metals, ceramics, polymers, composites, natural materials, bio-resorbable materials, or dissolvable materials. In a preferred embodiment of the present invention the implant tip is formed from surgical grade stainless steel.
- As best illustrated in
FIG. 15 ,tip 114 also includes an expandingportion 122. Expandingportion 122 is adapted to enlarge the puncture the incision initially created bypoint 118 to a shape that closely approximates the projected shape of the tipped implant. As shown inFIGS. 15 and 17 , expandingportion 122 is funnel-shaped so as to reduce trauma to the dilated tissue. Additionally, as illustrated inFIG. 15 , the maximum circumference of expandingportion 122 is preferably about the same size as or slightly larger thanimplant body 126. This ensures that the opening created by the tip is large enough so that the implant body does not catch or snag on the tissue surrounding the opening. Alternatively, the expanding portion can be configured to expand the opening created bypoint 118 to a circumference that is significantly larger than the circumference of the implant body. The expanding portion of the tip can also be configured to resist migration of the tippedimplant 110 in an undesirable direction. This can be accomplished by the addition of an arrow-shaped or lanciform expanding portion that readily penetrates and expands the target tissue as the tipped implant is moved in a first direction, yet resists movement in a second direction opposite the first direction. -
Tip 114 further includesshank 132, as illustrated inFIG. 17 .Shank 132 is located at the proximal end oftip 114, and is adapted to securetip 114 to implantbody 126. In addition,threads 134 are provided as a gripping surface to securely fastenimplant body 126 to tip 114.Implant body 126 is fastened toshank 132 and abuts the proximal end of the tip, as described in detail below. - In a third embodiment of the present invention, shown in
FIGS. 16, 18 and 19,medical device 110 is provided withpassageway 138.Passageway 138 extends axially through bothtip 114 andimplant body 126.Passageway 138 is adapted to slide over a guidewire, needle, or a cannula. The tip of the tippedimplant 110 can therefore be inserted into the target tissue with the proper orientation relative to the target tissue. As a result,passageway 138 facilitates insertion of tippedimplant 110. When the medical device is used in conjunction with a catheter, needle, or cannula, the target tissue can easily be pierced and infused with a desired fluid before insertion of the medical device. Other than the inclusion ofpassageway 138, the third embodiment of the tippedimplant 110 is the same as the second embodiment described above. - The
implant body 126 can be formed of a variety of desirable implant materials, such as those discussed with respect to the implant bodies of the first embodiment. As noted above, in a preferred embodiment of the present invention, the implant body is formed of purified submucosa, which is a bio-remodelable material that can be derived from, among other things, the small intestine submucosa of vertebrates. A biocompatible, radio-opaque powder or other marker can also be added to the implant body. This facilitates proper placement of the tipped implant within the patient. - A variety of methods can be employed to assemble tipped
implant 110. A preferred method of assembly includes securing the distal end of the tip, either manually or by a clamp. A rod is then inserted through the tip passageway. Thin strips of SIS are coiled around the shank and the rod as necessary to create an implant body having a desired diameter. Once the tipped implant is assembled, it is dried. The tipped implant can be air-dried or freeze-dried, preferably overnight. The dried implant body can then be cut to a desired size with a scalpel. - Another method of assembly is illustrated in
FIG. 19 and involves tamping strips of SIS material into a mold that grips the implant tip. In this particular method, a rod 146 is first inserted throughtip 114. An end of a strip of SIS material is then temporarily pinned to shank 132 (for example, by pressing the end of the strip to shank 132) and the remainder of the strip of SIS is loosely wrapped aroundshank 132 and a proximal portion of rod 146.Tip 114 is thereafter inserted intomold 142 far enough so thattip 114 engages and is retained byedge 158 ofmold 142. Once the tip and strip of SIS are inserted intomold 142, packing rod 154 is used to tamp the strip, or strips, of SIS toshank 132. The tip and strip of SIS is then dried in the mold, as described above with respect to the manually assembled implant. After the implant is dried in the mold,pusher rod 150 is used to remove the assembled implant body and tip frommold 142. As necessary, additional strips of SIS can be added to the tip by repeating the same process. Notably, drying the implant in the mold results in a smooth, low-profile implant that can be implanted more smoothly. - As shown in
FIGS. 20-26 , a preferred method of delivering the tipped implant generally includes first identifying the desired implant location with an endoscope and then inserting the tipped implant into that location. In particular, with reference toFIG. 20 ,endoscope 74 is passed through the mouth andesophagus 70 of a patient and delivered to the vicinity ofLES 82. Thereafter, aneedle 86 is passed through the working channel ofendoscope 74, as shown inFIG. 21 . Onceneedle 86 is located in a desired position within theLES 82, guidewire 90 is used to maintain access to the target tissue (FIG. 22 ).Guidewire 90 ultimately serves as a pilot for the delivery of the tipped implant into a precise location. Once the desired implant location is accessed byguidewire 90,needle 86 is removed (FIG. 23 ). The tippedimplant 110 is subsequently threaded over guidewire 90 (FIG. 24 ). The tipped implant is then pushed alongguidewire 90 toward the desired implant location. When the tipped implant reaches the target tissue, the tipped implant is pushed into the target tissue byconventional pusher tool 94. Once the tipped implant is in the target tissue, guidewire 90 is withdrawn (seeFIG. 25 ). As illustrated inFIG. 26 , this procedure may be repeated to insert as many tippedimplants 110 as necessary for a given medical condition. Preferably, an ultrasound endoscope can be used to identify the target area and serve as a working channel for the delivery of the tipped implant. It should be noted that the tipped implant can alternatively be delivered without the use of a guidewire. For example, the tipped implant can be delivered into a target tissue through a cannula or catheter, or over a needle by using a conventional pusher instrument. - Any other undisclosed or incidental details of the construction or composition of the various elements of the disclosed embodiment of the present invention are not believed to be critical to the achievement of the advantages of the present invention, so long as the elements possess the attributes needed for them to perform as disclosed. Certainly, in view of the present disclosure, one skilled in the medical arts would be able to conceive of a wide variety of additional implant body shapes, tips, sizes, strings, and successful combinations thereof. Indeed, the selection of these and other details of construction are believed to be well within the ability of one of even rudimental skills in this area, in view of the present disclosure. Likewise, one skilled in the medical arts would be able to conceive of a wide variety of applications and uses for linked or tipped implants in view of the present disclosure. Illustrative embodiments of the present invention have been described in considerable detail for the purpose of disclosing a practical, operative structure whereby the invention may be practiced advantageously. The designs described herein are intended to be exemplary only. The novel characteristics of the invention may be incorporated in other structural forms without departing from the spirit and scope of the invention. The invention encompasses embodiments both comprising and consisting of the elements described with reference to the illustrative embodiments. Unless otherwise indicated, all ordinary words and terms used herein shall take their customary meaning as defined in The American Heritage Dictionary, third edition. All technical terms shall take on their customary meaning as established by the appropriate technical discipline utilized by those normally skilled in that particular art area. All medical terms shall take their meaning as defined by Stedman 's Medical Dictionary, 27th edition.
Claims (34)
1. A medical device comprising a plurality of implant bodies and a first filament, wherein the plurality of implant bodies are disposed on the first filament.
2. The medical device of claim 1 , wherein the plurality of implant bodies comprise a bio-remodelable material.
3. The medical device of claim 2 , wherein the bio-remodelable material comprises an extracellular matrix.
4. The medical device of claim 3 , wherein the extracellular matrix is small intestine submucosa.
5. The medical device of claim 3 , wherein one or more of the plurality of implant bodies is spherical in shape.
6. The medical device of claim 3 , wherein one or more of the plurality of implant bodies is cylindrical in shape.
7. The medical device of claim 3 , wherein one or more of the plurality of implant bodies is cuboid in shape.
8. The medical device of claim 3 , wherein one or more of the plurality of implant bodies is ellipsoid in shape.
9. The medical device of claim 3 , further comprising a passageway extending through one or more of the plurality of implant bodies, the passageway being configured to receive a wire guide.
10. The medical device of claim 3 , further comprising a radiopaque marker operably connected to at least one of the plurality of implant bodies.
11. The medical device of claim 1 , wherein the first filament comprises a plurality of filaments operably connected to form a net, wherein the plurality of implant bodies are further disposed on the plurality of filaments.
12. A medical device, comprising:
an implant body comprising an exterior periphery; and
a penetrating member connected to the implant body, the penetrating member comprising a penetrating portion and an expanding portion located adjacent to the penetrating portion.
13. The medical device of claim 12 , wherein the penetrating portion is configured to pierce a bodily tissue.
14. The medical device of claim 13 , further comprising a passageway extending axially through the implant body and the penetrating member.
15. The medical device of claim 14 , wherein the penetrating member further comprises a shank located adjacent to the expanding portion, the shank being adapted to secure the implant body to the penetrating member.
16. The medical device of claim 15 , wherein the penetrating member further comprises an exterior periphery that is larger in size than the exterior periphery of the implant body.
17. The medical device of claim 15 , wherein the penetrating member further comprises an exterior periphery that is substantially equal in size to the exterior periphery of the implant body.
18. The medical device of claim 15 , wherein the penetrating member further comprises an exterior periphery that is smaller in size than the exterior periphery of the implant body.
19. The medical device of claim 12 , wherein the penetrating member is formed of a bio-compatible metal.
20. The medical device of claim 19 , wherein the implant body is formed of a bio-remodelable material.
21. The medical device of claim 20 , wherein the bio-remodelable material is an extracellular matrix.
22. The medical device of claim 12 , wherein the implant body is formed of a bio-resorbable material.
23. The medical device of claim 12 , wherein the implant body is formed of a synthetic material.
24. The medical device of claim 12 , wherein the penetrating portion defines a cutting edge.
25. The medical device of claim 12 , further comprising a passageway extending axially through the implant body and the penetrating member.
26. The medical device of claim 25 , wherein the penetrating member further comprises a shank located adjacent to the expanding portion, the shank being adapted to secure the implant body to the penetrating member.
27. The medical device of claim 26 , wherein the penetrating member further comprises an external periphery that is substantially equal to the size of the external periphery of the implant body.
28. The medical device of claim 27 , wherein the penetrating portion is infundibular.
29. The medical device of claim 28 wherein the penetrating portion defines a substantially circular cross-section.
30. The medical device of claim 28 wherein the penetrating portion defines a substantially triangular cross-section.
31. The medical device of claim 28 wherein the penetrating portion defines a substantially square cross-section.
32. The medical device of claim 12 , further comprising a solid shank located adjacent to the expanding portion, the shank being adapted to secure the implant body to the penetrating member.
33. A medical device, comprising:
an implant body having an outside diameter, the implant body being formed from an extracellular material;
a penetrating member connected to the implant body, the penetrating member comprising:
a piercing tip;
an expanding portion located adjacent to the piercing tip, the expanding having an outside diameter larger than the outside diameter of the implant body;
a shank located adjacent to the expanding portion, the shank being adapted to secure the implant body to the penetrating member; and
a passageway extending axially through the implant body and the penetrating member.
34. A method of implanting a medical device, the method comprising the steps of:
a) providing the medical device of claim 33 , an endoscope, and a needle having a distal end;
b) passing the endoscope through a patient's mouth and esophagus;
c) identifying a target location with the endoscope;
d) inserting the distal end of the needle into the target location;
e) delivering the medical device of claim 33 over the guidewire; and
f) inserting the medical device into the target location; and
g) withdrawing the needle and the endoscope from the patient's mouth and esophagus.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/915,626 US20050113855A1 (en) | 2003-08-11 | 2004-08-10 | Surgical implant |
US12/817,956 US8226730B2 (en) | 2003-08-11 | 2010-06-17 | Surgical implant |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49461303P | 2003-08-11 | 2003-08-11 | |
US55816304P | 2004-03-31 | 2004-03-31 | |
US10/915,626 US20050113855A1 (en) | 2003-08-11 | 2004-08-10 | Surgical implant |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/817,956 Continuation US8226730B2 (en) | 2003-08-11 | 2010-06-17 | Surgical implant |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050113855A1 true US20050113855A1 (en) | 2005-05-26 |
Family
ID=34221363
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/915,626 Abandoned US20050113855A1 (en) | 2003-08-11 | 2004-08-10 | Surgical implant |
US12/817,956 Active US8226730B2 (en) | 2003-08-11 | 2010-06-17 | Surgical implant |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/817,956 Active US8226730B2 (en) | 2003-08-11 | 2010-06-17 | Surgical implant |
Country Status (5)
Country | Link |
---|---|
US (2) | US20050113855A1 (en) |
EP (2) | EP2085049B1 (en) |
JP (1) | JP4673305B2 (en) |
DE (1) | DE602004023302D1 (en) |
WO (1) | WO2005018468A2 (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050071012A1 (en) * | 2003-09-30 | 2005-03-31 | Hassan Serhan | Methods and devices to replace spinal disc nucleus pulposus |
US20060142789A1 (en) * | 2004-12-15 | 2006-06-29 | Wilson-Cook Medical Inc. | Method and apparatus for augmentation of a sphincter |
US20060258974A1 (en) * | 2005-04-25 | 2006-11-16 | Wilson-Cook Medical Inc. | Object-delivery shuttle |
US20070112360A1 (en) * | 2005-11-15 | 2007-05-17 | Patrick De Deyne | Bioprosthetic device |
US20070162132A1 (en) * | 2005-12-23 | 2007-07-12 | Dominique Messerli | Flexible elongated chain implant and method of supporting body tissue with same |
US20090248115A1 (en) * | 2008-03-26 | 2009-10-01 | Corndorf Eric D | Telemetry Control for Implantable Medical Devices |
US20090287239A1 (en) * | 2008-05-16 | 2009-11-19 | Ams Research Corporation | Tissue Bulking Device and Method |
US20100185290A1 (en) * | 2007-06-29 | 2010-07-22 | Curtis Compton | Flexible chain implants and instrumentation |
US20100256778A1 (en) * | 2003-08-11 | 2010-10-07 | Wilson-Cook Medical Inc. | Surgical Implant |
US20110303228A1 (en) * | 2010-06-14 | 2011-12-15 | Coloplast A/S | Incontinence treatment system |
US8231624B1 (en) * | 2010-12-22 | 2012-07-31 | Strippgen Walter E | Dynamic surgical implant |
US9023085B2 (en) | 2010-12-22 | 2015-05-05 | Walter E. Strippgen | Dynamic surgical implant |
US9238151B2 (en) | 2004-07-23 | 2016-01-19 | Varian Medical Systems, Inc. | Dynamic/adaptive treatment planning for radiation therapy |
US9586059B2 (en) | 2004-07-23 | 2017-03-07 | Varian Medical Systems, Inc. | User interface for guided radiation therapy |
US9943704B1 (en) * | 2009-01-21 | 2018-04-17 | Varian Medical Systems, Inc. | Method and system for fiducials contained in removable device for radiation therapy |
US20180271659A1 (en) * | 2015-01-09 | 2018-09-27 | Formae, Inc. | Rigid segmented flexible anchors |
US20180289467A1 (en) * | 2017-04-05 | 2018-10-11 | Ernesto Andrade | Dispensing device, kit, and method for tissue augmentation |
US10182868B2 (en) | 2005-11-17 | 2019-01-22 | Varian Medical Systems, Inc. | Apparatus and methods for using an electromagnetic transponder in orthopedic procedures |
WO2020077229A1 (en) * | 2018-10-11 | 2020-04-16 | Moises Jacobs | Improved gastroesophageal reflux treatment system, method, and device |
US10653496B2 (en) | 2005-09-19 | 2020-05-19 | Varian Medical Systems, Inc. | Apparatus and methods for implanting objects, such as a bronchoscopically implanting markers in the lung of patients |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4525931B2 (en) * | 2006-03-31 | 2010-08-18 | 哲男 荒川 | Backflow prevention device and method for mounting the same |
US20080058840A1 (en) * | 2006-09-01 | 2008-03-06 | Albrecht Thomas E | Implantable coil for insertion into a hollow body organ |
WO2010087773A1 (en) * | 2009-01-29 | 2010-08-05 | Milux Holding S.A. | An apparatus for treating gerd |
EP2240138B1 (en) | 2008-01-29 | 2021-07-21 | Implantica Patent Ltd. | Apparatus for treating obesity |
US20100160995A1 (en) * | 2008-12-18 | 2010-06-24 | Jerome Dargent | Method for treating obesity |
EP3388034A1 (en) * | 2009-01-29 | 2018-10-17 | Kirk Promotion LTD. | An apparatus for treating gerd |
ES2896937T3 (en) * | 2009-01-29 | 2022-02-28 | Implantica Patent Ltd | obesity treatment |
LT2405869T (en) * | 2009-01-29 | 2021-11-10 | Implantica Patent Ltd. | Obesity treatment |
US20110106110A1 (en) * | 2009-10-30 | 2011-05-05 | Warsaw Orthopedic, Inc. | Devices and methods for implanting a plurality of drug depots having one or more anchoring members |
KR101362446B1 (en) * | 2012-05-10 | 2014-02-11 | 이훈범 | Filler for wrinkle removing |
KR101696253B1 (en) * | 2013-05-10 | 2017-01-13 | 주식회사 에스트라 | Filler for removing wrinkles |
US9775978B2 (en) | 2014-07-25 | 2017-10-03 | Warsaw Orthopedic, Inc. | Drug delivery device and methods having a retaining member |
US10080877B2 (en) | 2014-07-25 | 2018-09-25 | Warsaw Orthopedic, Inc. | Drug delivery device and methods having a drug cartridge |
US10076650B2 (en) | 2015-11-23 | 2018-09-18 | Warsaw Orthopedic, Inc. | Enhanced stylet for drug depot injector |
US10549081B2 (en) | 2016-06-23 | 2020-02-04 | Warsaw Orthopedic, Inc. | Drug delivery device and methods having a retaining member |
US10434261B2 (en) | 2016-11-08 | 2019-10-08 | Warsaw Orthopedic, Inc. | Drug pellet delivery system and method |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3818894A (en) * | 1971-01-22 | 1974-06-25 | Ceskoslovenska Akademie Ved | Laryngeal implant |
US4675683A (en) * | 1985-03-28 | 1987-06-23 | Robinson Charles R | Spent hunting arrow locating means |
US5207695A (en) * | 1989-06-19 | 1993-05-04 | Trout Iii Hugh H | Aortic graft, implantation device, and method for repairing aortic aneurysm |
US5304123A (en) * | 1991-10-24 | 1994-04-19 | Children's Medical Center Corporation | Detachable balloon catheter for endoscopic treatment of vesicoureteral reflux |
US5336263A (en) * | 1992-04-06 | 1994-08-09 | Robert A. Ersek | Treatment of urological and gastric fluid reflux disorders by injection of mmicro particles |
US5785680A (en) * | 1994-06-13 | 1998-07-28 | Texas Instruments Incorporated | Injector and object to be injected by the injector |
US6098629A (en) * | 1999-04-07 | 2000-08-08 | Endonetics, Inc. | Submucosal esophageal bulking device |
US6238403B1 (en) * | 1999-10-04 | 2001-05-29 | Microvention, Inc. | Filamentous embolic device with expansible elements |
US6338345B1 (en) * | 1999-04-07 | 2002-01-15 | Endonetics, Inc. | Submucosal prosthesis delivery device |
US20020072720A1 (en) * | 2000-12-11 | 2002-06-13 | Hague Clifford W. | Rigid soluble materials for use with needle-less infusion sets, sensor sets and injection devices and methods of making the same |
US7047981B2 (en) * | 1998-07-06 | 2006-05-23 | Boston Scientific Scimed, Inc. | Implant system and method for bulking tissue |
US7235078B2 (en) * | 2002-11-26 | 2007-06-26 | Hs West Investments Llc | Protective devices for use with angled interference screws |
Family Cites Families (166)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1867624A (en) * | 1930-04-01 | 1932-07-19 | Memorial Hospital For The Trea | Device for obtaining biopsy specimens |
US1969671A (en) * | 1931-12-03 | 1934-08-07 | Adair Royalties Co Inc | Cervical tampon applier |
US2831485A (en) * | 1955-06-27 | 1958-04-22 | Joseph R Crockford | Tampons |
US3094122A (en) * | 1961-01-18 | 1963-06-18 | Theophile E Gauthier | Flexible cannula and intravenous needle combined |
US3965905A (en) * | 1972-07-13 | 1976-06-29 | Warner-Lambert Company | Catamenial tampon |
CA1019638A (en) * | 1973-05-16 | 1977-10-25 | John C. Muirhead | Liquid injection projectile |
DE2722286C2 (en) * | 1977-05-17 | 1986-04-17 | Coloplast A/S, Espergaerde | Non-magnetic tampon for closing an artificial anus and process for its production |
US4479791A (en) * | 1980-07-28 | 1984-10-30 | Tampax Incorporated | Tampon applicator |
US5601557A (en) * | 1982-05-20 | 1997-02-11 | Hayhurst; John O. | Anchoring and manipulating tissue |
US4697575A (en) * | 1984-11-21 | 1987-10-06 | Henry Ford Hospital | Delivery system for interstitial radiation therapy including substantially non-deflecting elongated member |
US4832680A (en) * | 1986-07-03 | 1989-05-23 | C.R. Bard, Inc. | Apparatus for hypodermically implanting a genitourinary prosthesis |
US4773393A (en) * | 1986-07-03 | 1988-09-27 | C. R. Bard, Inc. | Hypodermically implantable genitourinary prosthesis |
US4800900A (en) * | 1986-11-04 | 1989-01-31 | Vance Products, Inc. | External strap incontinence control device |
US4786276A (en) * | 1987-07-01 | 1988-11-22 | Habley Medical Technology Corporation | Triple cushion sphincteric web |
DK162185C (en) * | 1987-09-15 | 1998-02-23 | Linda Jonasson | Device for preventing involuntary discharge of urine |
US5224497A (en) * | 1988-07-06 | 1993-07-06 | Ehlers Robert L | Method of removing diverticula in the colon |
CA1327424C (en) * | 1988-09-16 | 1994-03-08 | James C. Armour | Compact tampon applicator |
US5013292A (en) * | 1989-02-24 | 1991-05-07 | R. Laborie Medical Corporation | Surgical correction of female urinary stress incontinence and kit therefor |
US5193263A (en) * | 1989-07-19 | 1993-03-16 | Asahi Kogaku Kogyo Kabushiki Kaisha | Method of securing skin tube to bendable tube portion of endoscope |
US4978323A (en) * | 1989-08-10 | 1990-12-18 | George Freedman | System and method for preventing closure of passageways |
US5749879A (en) * | 1989-08-16 | 1998-05-12 | Medtronic, Inc. | Device or apparatus for manipulating matter |
CA2030716C (en) * | 1989-12-27 | 1996-07-02 | Robert L. Billmers | Water disposable tampon applicators and biodegradable compositions for use therein |
US5041077A (en) * | 1990-10-26 | 1991-08-20 | George Kulick | Intravaginal incontinence prosthesis |
US5584827A (en) * | 1992-05-18 | 1996-12-17 | Ultracell Medical Technologies, Inc | Nasal-packing article |
US6592859B1 (en) * | 1992-08-20 | 2003-07-15 | Ethicon, Inc. | Controlled expansion sphincter augmentation media |
DE9213656U1 (en) * | 1992-10-09 | 1992-12-03 | Angiomed Ag, 7500 Karlsruhe, De | |
DK95193D0 (en) * | 1993-08-20 | 1993-08-20 | Coloplast As | DEVELOPMENT TO PREVENT UNLOCKED WATER |
US5755706A (en) * | 1993-09-16 | 1998-05-26 | Xomed Surgical Products, Inc. | Flexible stranded sponge pack |
US5527342A (en) * | 1993-12-14 | 1996-06-18 | Pietrzak; William S. | Method and apparatus for securing soft tissues, tendons and ligaments to bone |
US5549633A (en) * | 1994-08-24 | 1996-08-27 | Kensey Nash Corporation | Apparatus and methods of use for preventing blood seepage at a percutaneous puncture site |
US6132438A (en) * | 1995-06-07 | 2000-10-17 | Ep Technologies, Inc. | Devices for installing stasis reducing means in body tissue |
US6090063A (en) * | 1995-12-01 | 2000-07-18 | C. R. Bard, Inc. | Device, system and method for implantation of filaments and particles in the body |
US5722931A (en) * | 1996-03-05 | 1998-03-03 | Urohealth Systems, Inc. | Female incontinence device |
JPH09268412A (en) * | 1996-03-27 | 1997-10-14 | Art Neichiyaa:Kk | Head wig and fixation of implanted hair |
US5906575A (en) * | 1996-04-25 | 1999-05-25 | Rochester Medical Corporation | Urethral urine retention device |
DE19621420C2 (en) * | 1996-05-28 | 1998-12-03 | Engel Konrad Dr Med | Device for treating male and female urinary bladder emptying disorders |
GB9622711D0 (en) * | 1996-10-31 | 1997-01-08 | British Tech Group | Instrument having enhanced ultrasound visibility |
US5749826A (en) * | 1996-11-06 | 1998-05-12 | Faulkner; James W. | Urinary incontinence control device |
JP4074666B2 (en) | 1996-12-10 | 2008-04-09 | クック バイオテック、インク. | Tubular grafts from purified submucosa |
CA2259914C (en) * | 1997-05-08 | 2007-12-18 | C.R. Bard, Inc. | Tmr stent and delivery system |
US6167886B1 (en) * | 1997-05-28 | 2001-01-02 | Medi-Globe Vertriebs Gmbh | Device for treatment of male and female urinary incontinence |
US6045498A (en) * | 1997-06-12 | 2000-04-04 | Uromedica, Inc. | Method for adjustably restricting a body lumen |
US6042535A (en) * | 1997-07-17 | 2000-03-28 | Srs Medical Systems, Inc. | Flow-around valve |
US6638308B2 (en) * | 1997-10-10 | 2003-10-28 | John D. Corbitt, Jr. | Bioabsorbable breast implant |
US6270464B1 (en) * | 1998-06-22 | 2001-08-07 | Artemis Medical, Inc. | Biopsy localization method and device |
US6056687A (en) * | 1997-12-04 | 2000-05-02 | American Medical Systems, Inc. | Device for alleviating urinary incontinence |
US20030135206A1 (en) * | 1998-02-27 | 2003-07-17 | Curon Medical, Inc. | Method for treating a sphincter |
PL186960B1 (en) * | 1998-05-04 | 2004-04-30 | Adamed Sp Z Oo | Intravaginal set and therapeutic method employing that set |
US6740082B2 (en) * | 1998-12-29 | 2004-05-25 | John H. Shadduck | Surgical instruments for treating gastro-esophageal reflux |
US6599311B1 (en) * | 1998-06-05 | 2003-07-29 | Broncus Technologies, Inc. | Method and assembly for lung volume reduction |
US6067991A (en) * | 1998-08-13 | 2000-05-30 | Forsell; Peter | Mechanical food intake restriction device |
EP0993843B1 (en) * | 1998-10-14 | 2006-04-26 | Terumo Kabushiki Kaisha | Radiation source delivery wire and catheter assembly for radiation therapy |
US6251064B1 (en) * | 1998-12-11 | 2001-06-26 | Enteric Medical Technologies, Inc. | Method for creating valve-like mechanism in natural body passageway |
US6238335B1 (en) * | 1998-12-11 | 2001-05-29 | Enteric Medical Technologies, Inc. | Method for treating gastroesophageal reflux disease and apparatus for use therewith |
US7846180B2 (en) * | 1999-06-22 | 2010-12-07 | Ethicon Endo-Surgery, Inc. | Tissue fixation devices and methods of fixing tissue |
US6626899B2 (en) * | 1999-06-25 | 2003-09-30 | Nidus Medical, Llc | Apparatus and methods for treating tissue |
US6358197B1 (en) * | 1999-08-13 | 2002-03-19 | Enteric Medical Technologies, Inc. | Apparatus for forming implants in gastrointestinal tract and kit for use therewith |
US6390096B1 (en) * | 1999-09-17 | 2002-05-21 | Pi Medical, Inc. | Needle with pre-loaded implant for snoring treatment |
US6450169B1 (en) * | 1999-09-17 | 2002-09-17 | Pi Medical, Inc. | Braided implant for snoring treatment |
CN1250167C (en) * | 1999-10-04 | 2006-04-12 | 微温森公司 | Filamentous embolic device with expansible elements |
US6264600B1 (en) * | 1999-10-21 | 2001-07-24 | Peter D. Grimm | Hollow suture member with radioactive seeds positioned therein for treatment of prostate cancer |
US6387104B1 (en) * | 1999-11-12 | 2002-05-14 | Scimed Life Systems, Inc. | Method and apparatus for endoscopic repair of the lower esophageal sphincter |
US7887551B2 (en) * | 1999-12-02 | 2011-02-15 | Smith & Nephew, Inc. | Soft tissue attachment and repair |
US6402677B1 (en) * | 1999-12-17 | 2002-06-11 | C.R. Bard, Inc. | Brachytherapy seed needle with window |
US6450937B1 (en) * | 1999-12-17 | 2002-09-17 | C. R. Bard, Inc. | Needle for implanting brachytherapy seeds |
EP1114618A3 (en) * | 2000-01-04 | 2001-08-22 | Ethicon Endo-Surgery, Inc. | Surgical instrument for applying beads to tissue |
US6361487B1 (en) * | 2000-03-09 | 2002-03-26 | Neoseed Technology Llc | Method and apparatus for brachytherapy treatment of prostate disease |
US6450938B1 (en) * | 2000-03-21 | 2002-09-17 | Promex, Llc | Brachytherapy device |
US6572525B1 (en) * | 2000-05-26 | 2003-06-03 | Lisa Yoshizumi | Needle having an aperture for detecting seeds or spacers loaded therein and colored seeds or spacers |
US6540789B1 (en) * | 2000-06-15 | 2003-04-01 | Scimed Life Systems, Inc. | Method for treating morbid obesity |
US6572577B1 (en) * | 2000-06-23 | 2003-06-03 | Mcneil-Ppc, Inc. | Applicator for catamenial device having improved gripper end |
WO2002011696A2 (en) * | 2000-08-08 | 2002-02-14 | Ev & M | Active tissue augmentation materials and method |
AR030341A1 (en) * | 2000-08-14 | 2003-08-20 | Novartis Ag | MOLDED BIOMEDICAL ITEMS |
US8454552B2 (en) * | 2000-08-24 | 2013-06-04 | Cardiac Science Corporation | Method for constructing an instrument with a covered bore for subcutaneous implantation |
US6432040B1 (en) * | 2000-09-14 | 2002-08-13 | Nizam N. Meah | Implantable esophageal sphincter apparatus for gastroesophageal reflux disease and method |
WO2003028808A2 (en) * | 2000-10-25 | 2003-04-10 | Lamoureux Gary A | Pre-loaded needle assembly |
US6689047B2 (en) * | 2000-11-15 | 2004-02-10 | Scimed Life Systems, Inc. | Treating urinary incontinence |
EP1210912A3 (en) * | 2000-11-27 | 2003-12-17 | Terumo Kabushiki Kaisha | Instrument for extroverting blood vessel |
US6730014B2 (en) * | 2001-01-05 | 2004-05-04 | Peter J. Wilk | Medical treatment method and device utilizing magnetic particles |
DE10110513A1 (en) * | 2001-01-29 | 2002-12-12 | Ulrich Werth | Implant and method and device for inserting the implant into living tissue |
US6497646B1 (en) * | 2001-03-14 | 2002-12-24 | Cordis Corporation | Intravascular radiotherapy source ribbon having variable radiopacity |
US6595911B2 (en) * | 2001-04-03 | 2003-07-22 | Lovuolo Michael | Method and device for anchor implantation and support of bodily structures |
US6632235B2 (en) * | 2001-04-19 | 2003-10-14 | Synthes (U.S.A.) | Inflatable device and method for reducing fractures in bone and in treating the spine |
WO2002085190A2 (en) * | 2001-04-24 | 2002-10-31 | Kim Young D | Magnetic pellets and system for assisting ventricular contraction |
US7020531B1 (en) * | 2001-05-01 | 2006-03-28 | Intrapace, Inc. | Gastric device and suction assisted method for implanting a device on a stomach wall |
US7756582B2 (en) * | 2001-05-01 | 2010-07-13 | Intrapace, Inc. | Gastric stimulation anchor and method |
US6558400B2 (en) * | 2001-05-30 | 2003-05-06 | Satiety, Inc. | Obesity treatment tools and methods |
US6902570B2 (en) * | 2001-06-08 | 2005-06-07 | Rolf Dieter Schraft | Device and method for connecting hollow organs and/or sealing wall defects in hollow organs |
US6692510B2 (en) * | 2001-06-14 | 2004-02-17 | Cordis Neurovascular, Inc. | Aneurysm embolization device and deployment system |
US6599310B2 (en) * | 2001-06-29 | 2003-07-29 | Quill Medical, Inc. | Suture method |
US6569077B2 (en) * | 2001-07-11 | 2003-05-27 | Bruno Schmidt | Dimpled seed implant needle |
US20050177180A1 (en) * | 2001-11-28 | 2005-08-11 | Aptus Endosystems, Inc. | Devices, systems, and methods for supporting tissue and/or structures within a hollow body organ |
DE10204818C2 (en) * | 2002-02-06 | 2003-11-27 | Eurotope Entwicklungsgesellsch | Device and method for loading implantation needles with radiation sources from radiation source chains for interstitial brachytherapy of tissue |
US7749151B2 (en) * | 2002-04-04 | 2010-07-06 | Cp Medical, Inc. | Brachytherapy spacer |
US20050250973A1 (en) * | 2002-04-04 | 2005-11-10 | Ferguson Patrick J | Hollow bioabsorbable elements for positioning material in living tissue |
US7047980B2 (en) * | 2002-04-09 | 2006-05-23 | Promethean Surgical Devices Llc | Treatment for Gastroesophageal disease |
US7695427B2 (en) * | 2002-04-26 | 2010-04-13 | Torax Medical, Inc. | Methods and apparatus for treating body tissue sphincters and the like |
US6790214B2 (en) * | 2002-05-17 | 2004-09-14 | Esophyx, Inc. | Transoral endoscopic gastroesophageal flap valve restoration device, assembly, system and method |
US7166122B2 (en) * | 2002-06-27 | 2007-01-23 | Boston Scientific Scimed, Inc. | Anchor assemblies in stretch-resistant vaso-occlusive coils |
US7175589B2 (en) * | 2002-07-02 | 2007-02-13 | The Foundry Inc. | Methods and devices for luminal and sphincter augmentation |
US20040019388A1 (en) * | 2002-07-24 | 2004-01-29 | Starkebaum Warren L. | Methods and implants for retarding stomach emptying to treat eating disorders |
US7214233B2 (en) * | 2002-08-30 | 2007-05-08 | Satiety, Inc. | Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach |
US7824701B2 (en) * | 2002-10-18 | 2010-11-02 | Ethicon, Inc. | Biocompatible scaffold for ligament or tendon repair |
FR2851451B1 (en) * | 2003-02-24 | 2005-05-20 | Sofradim Production | DEVICE FOR LIGATURING ANATOMICAL STRUCTURE |
US7322928B2 (en) * | 2003-03-17 | 2008-01-29 | Medi-Physics, Inc. | Products and methods for brachytherapy |
USD572362S1 (en) * | 2003-04-04 | 2008-07-01 | Playtex Products, Inc. | Tampon applicator with finger grip |
US7175638B2 (en) * | 2003-04-16 | 2007-02-13 | Satiety, Inc. | Method and devices for modifying the function of a body organ |
US7037252B2 (en) * | 2003-05-05 | 2006-05-02 | Draxis Specialty Pharmaceuticals, Inc. | Brachytherapy seed transport devices and methods for using same |
US7316706B2 (en) * | 2003-06-20 | 2008-01-08 | Medtronic Vascular, Inc. | Tensioning device, system, and method for treating mitral valve regurgitation |
EP2085049B1 (en) * | 2003-08-11 | 2019-06-19 | Cook Medical Technologies LLC | Surgical implant with penetrating tip |
WO2005023321A2 (en) * | 2003-09-04 | 2005-03-17 | Cook Biotech Incorporated | Extracellular matrix composite materials, and manufacture and use thereof |
WO2005032473A2 (en) * | 2003-10-02 | 2005-04-14 | Depuy Spine, Inc. | Chemical treatment for removing cellular and nuclear material from naturally occurring extracellular matrix-based biomaterials |
EP1682009B1 (en) * | 2003-10-03 | 2014-03-05 | Boston Scientific Limited, an Irish company | Systems for a delivering a medical implant to an anatomical location in a patient |
US20050247320A1 (en) * | 2003-10-10 | 2005-11-10 | Stack Richard S | Devices and methods for retaining a gastro-esophageal implant |
US7381180B2 (en) * | 2003-10-31 | 2008-06-03 | Medtronic, Inc. | Implantable devices and methods for treating fecal incontinence |
US7316822B2 (en) * | 2003-11-26 | 2008-01-08 | Ethicon, Inc. | Conformable tissue repair implant capable of injection delivery |
US7347863B2 (en) * | 2004-05-07 | 2008-03-25 | Usgi Medical, Inc. | Apparatus and methods for manipulating and securing tissue |
JP4249047B2 (en) * | 2004-01-30 | 2009-04-02 | ユニ・チャーム株式会社 | Sanitary tampons |
CA2556228C (en) * | 2004-02-13 | 2014-05-13 | Satiety, Inc. | Methods for reducing hollow organ volume |
AU2005218318A1 (en) * | 2004-02-27 | 2005-09-15 | Ethicon Endo-Surgery, Inc | Methods and devices for reducing hollow organ volume |
US7703459B2 (en) * | 2004-03-09 | 2010-04-27 | Usgi Medical, Inc. | Apparatus and methods for mapping out endoluminal gastrointestinal surgery |
US20050216043A1 (en) * | 2004-03-26 | 2005-09-29 | Blatter Duane D | Stented end graft vessel device for anastomosis and related methods for percutaneous placement |
EP1740132B1 (en) * | 2004-04-26 | 2014-12-31 | Synecor, LLC | Restrictive and/or obstructive implant for inducing weight loss |
US20050246037A1 (en) * | 2004-04-30 | 2005-11-03 | Medtronic, Inc. | Partial esophageal obstruction to limit food intake for treatment of obesity |
US7520884B2 (en) * | 2004-05-07 | 2009-04-21 | Usgi Medical Inc. | Methods for performing gastroplasty |
US20050261711A1 (en) * | 2004-05-24 | 2005-11-24 | Olympus Corporation | Treatment method and endoscope apparatus |
JP2008505099A (en) * | 2004-06-30 | 2008-02-21 | タイコ ヘルスケア グループ リミテッド パートナーシップ | Isocyanate-based compositions and uses thereof |
US7361135B2 (en) * | 2004-08-24 | 2008-04-22 | C R Bard, Inc | Brachytherapy system for dispensing medication |
US7244270B2 (en) * | 2004-09-16 | 2007-07-17 | Evera Medical | Systems and devices for soft tissue augmentation |
US7641688B2 (en) * | 2004-09-16 | 2010-01-05 | Evera Medical, Inc. | Tissue augmentation device |
US20060058890A1 (en) * | 2004-09-16 | 2006-03-16 | Lesh Michael D | Methods for soft tissue augmentation |
US7305993B2 (en) * | 2004-10-26 | 2007-12-11 | Medtronic, Inc. | Implantation of tissue bulking devices |
US7780592B2 (en) * | 2004-10-29 | 2010-08-24 | Medtronic, Inc. | Distal portion of an endoscopic delivery system |
US7833281B2 (en) * | 2004-12-15 | 2010-11-16 | Lehman Glen A | Method and apparatus for augmentation of a sphincter |
US7150709B1 (en) * | 2004-12-24 | 2006-12-19 | Bruno Schmidt | Wax-less implant system |
US7736392B2 (en) * | 2005-04-28 | 2010-06-15 | Medtronic, Inc. | Bulking of upper esophageal sphincter for treatment of obesity |
US7984717B2 (en) * | 2005-04-29 | 2011-07-26 | Medtronic, Inc. | Devices for augmentation of lumen walls |
US7632313B2 (en) * | 2005-04-29 | 2009-12-15 | Jmea Corporation | Disc repair system |
US7736293B2 (en) * | 2005-07-22 | 2010-06-15 | Biocompatibles Uk Limited | Implants for use in brachytherapy and other radiation therapy that resist migration and rotation |
US7815562B2 (en) * | 2005-08-11 | 2010-10-19 | Boston Scientific Scimed, Inc. | Tubular implantable sling and related delivery systems, methods and devices |
US7875041B2 (en) * | 2005-09-28 | 2011-01-25 | Olympus Medical Systems Corp. | Suturing method for penetrating hole |
US20070078291A1 (en) * | 2005-09-30 | 2007-04-05 | North American Scientific | Needle assembly with enhanced steerability |
US8123768B2 (en) * | 2005-10-24 | 2012-02-28 | Gil Vardi | Method and system to restrict stomach size |
US7862496B2 (en) * | 2005-11-10 | 2011-01-04 | Cianna Medical, Inc. | Brachytherapy apparatus and methods for using them |
US7604586B2 (en) * | 2006-04-18 | 2009-10-20 | Wazer David E | Radioactive therapeutic apparatus |
CA2653617C (en) * | 2006-06-02 | 2016-08-30 | Cianna Medical, Inc. | Expandable brachytherapy apparatus |
CA2936752A1 (en) * | 2006-06-22 | 2007-12-27 | Ams Research Corporation | Adjustable tension incontinence sling assemblies |
USD615202S1 (en) * | 2006-06-23 | 2010-05-04 | Playtex Products, Inc. | Tampon applicator with finger grip |
US7749235B2 (en) * | 2006-10-20 | 2010-07-06 | Ethicon Endo-Surgery, Inc. | Stomach invagination method and apparatus |
US7862502B2 (en) * | 2006-10-20 | 2011-01-04 | Ellipse Technologies, Inc. | Method and apparatus for adjusting a gastrointestinal restriction device |
WO2008085994A2 (en) * | 2007-01-08 | 2008-07-17 | Endogastric Solutions | Connected fasteners, delivery device and method |
JP5400621B2 (en) * | 2007-02-21 | 2014-01-29 | コヴィディエン リミテッド パートナーシップ | Obturator tip |
JP5174891B2 (en) * | 2007-04-27 | 2013-04-03 | シーヴィ デヴァイシズ,エルエルシー | Devices, systems, and methods for accessing the epicardial surface of the heart |
WO2008152435A1 (en) * | 2007-06-12 | 2008-12-18 | PROMEDON DO BRASIL PRODUTOS MéDICO HOSPITALARES LTDA. | Micro sling and implantation tool for urinary incontinence and faecal incontinence treatment |
US8066689B2 (en) * | 2007-07-11 | 2011-11-29 | Apollo Endosurgery, Inc. | Methods and systems for submucosal implantation of a device for diagnosis and treatment with a therapeutic agent |
US20090030260A1 (en) * | 2007-07-25 | 2009-01-29 | Mick Radio-Nuclear Instruments, Inc. | Seed anchor |
EP2207488B1 (en) * | 2007-10-09 | 2012-09-26 | Cook Medical Technologies LLC | Magnetic anastomosis device having improved delivery |
US20090112059A1 (en) * | 2007-10-31 | 2009-04-30 | Nobis Rudolph H | Apparatus and methods for closing a gastrotomy |
USD647612S1 (en) * | 2008-01-17 | 2011-10-25 | Ontex Hygieneartikel Deutschland Gmbh | Tampon |
US8048053B2 (en) * | 2008-04-14 | 2011-11-01 | The Procter & Gamble Company | Tampon having an auxiliary patch |
US20100113866A1 (en) * | 2008-11-03 | 2010-05-06 | Ian Lee Goldman | Atraumatic medical device anchoring and delivery system |
EP2389115B1 (en) * | 2008-12-19 | 2018-02-28 | Covidien LP | Navigable tissue treatment tools |
AU2009335121B2 (en) * | 2008-12-31 | 2015-03-26 | 3M Innovative Properties Company | Tissue roll scaffolds |
WO2010105158A1 (en) * | 2009-03-12 | 2010-09-16 | Icecure Medical Ltd. | Combined cryotherapy and brachytherapy device and method |
US20110306820A1 (en) * | 2010-06-14 | 2011-12-15 | Coloplast A/S | Method of treating incontinence |
EP2605820A4 (en) * | 2010-08-20 | 2014-10-29 | Univ Wake Forest Health Sciences | Tethered and/or visually coded brachytherapy devices and related methods |
-
2004
- 2004-08-10 EP EP09159223.8A patent/EP2085049B1/en active Active
- 2004-08-10 EP EP04780586A patent/EP1656070B1/en active Active
- 2004-08-10 WO PCT/US2004/025777 patent/WO2005018468A2/en active Application Filing
- 2004-08-10 DE DE602004023302T patent/DE602004023302D1/en active Active
- 2004-08-10 US US10/915,626 patent/US20050113855A1/en not_active Abandoned
- 2004-08-10 JP JP2006523284A patent/JP4673305B2/en active Active
-
2010
- 2010-06-17 US US12/817,956 patent/US8226730B2/en active Active
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3818894A (en) * | 1971-01-22 | 1974-06-25 | Ceskoslovenska Akademie Ved | Laryngeal implant |
US4675683A (en) * | 1985-03-28 | 1987-06-23 | Robinson Charles R | Spent hunting arrow locating means |
US5207695A (en) * | 1989-06-19 | 1993-05-04 | Trout Iii Hugh H | Aortic graft, implantation device, and method for repairing aortic aneurysm |
US5304123A (en) * | 1991-10-24 | 1994-04-19 | Children's Medical Center Corporation | Detachable balloon catheter for endoscopic treatment of vesicoureteral reflux |
US5336263A (en) * | 1992-04-06 | 1994-08-09 | Robert A. Ersek | Treatment of urological and gastric fluid reflux disorders by injection of mmicro particles |
US5785680A (en) * | 1994-06-13 | 1998-07-28 | Texas Instruments Incorporated | Injector and object to be injected by the injector |
US7047981B2 (en) * | 1998-07-06 | 2006-05-23 | Boston Scientific Scimed, Inc. | Implant system and method for bulking tissue |
US6098629A (en) * | 1999-04-07 | 2000-08-08 | Endonetics, Inc. | Submucosal esophageal bulking device |
US6338345B1 (en) * | 1999-04-07 | 2002-01-15 | Endonetics, Inc. | Submucosal prosthesis delivery device |
US6299619B1 (en) * | 1999-10-04 | 2001-10-09 | Microvention, Inc. | Methods for embolizing a target vascular site |
US6238403B1 (en) * | 1999-10-04 | 2001-05-29 | Microvention, Inc. | Filamentous embolic device with expansible elements |
US20020072720A1 (en) * | 2000-12-11 | 2002-06-13 | Hague Clifford W. | Rigid soluble materials for use with needle-less infusion sets, sensor sets and injection devices and methods of making the same |
US7235078B2 (en) * | 2002-11-26 | 2007-06-26 | Hs West Investments Llc | Protective devices for use with angled interference screws |
Cited By (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8226730B2 (en) * | 2003-08-11 | 2012-07-24 | Cook Medical Technologies Llc | Surgical implant |
US20100256778A1 (en) * | 2003-08-11 | 2010-10-07 | Wilson-Cook Medical Inc. | Surgical Implant |
US20050071012A1 (en) * | 2003-09-30 | 2005-03-31 | Hassan Serhan | Methods and devices to replace spinal disc nucleus pulposus |
US9586059B2 (en) | 2004-07-23 | 2017-03-07 | Varian Medical Systems, Inc. | User interface for guided radiation therapy |
US9238151B2 (en) | 2004-07-23 | 2016-01-19 | Varian Medical Systems, Inc. | Dynamic/adaptive treatment planning for radiation therapy |
US20060142789A1 (en) * | 2004-12-15 | 2006-06-29 | Wilson-Cook Medical Inc. | Method and apparatus for augmentation of a sphincter |
US7833281B2 (en) * | 2004-12-15 | 2010-11-16 | Lehman Glen A | Method and apparatus for augmentation of a sphincter |
US20060258974A1 (en) * | 2005-04-25 | 2006-11-16 | Wilson-Cook Medical Inc. | Object-delivery shuttle |
US7811245B2 (en) * | 2005-04-25 | 2010-10-12 | Wilson-Cook Medical Inc. | Object-delivery shuttle |
US10653496B2 (en) | 2005-09-19 | 2020-05-19 | Varian Medical Systems, Inc. | Apparatus and methods for implanting objects, such as a bronchoscopically implanting markers in the lung of patients |
US20070112360A1 (en) * | 2005-11-15 | 2007-05-17 | Patrick De Deyne | Bioprosthetic device |
US10182868B2 (en) | 2005-11-17 | 2019-01-22 | Varian Medical Systems, Inc. | Apparatus and methods for using an electromagnetic transponder in orthopedic procedures |
US9289240B2 (en) | 2005-12-23 | 2016-03-22 | DePuy Synthes Products, Inc. | Flexible elongated chain implant and method of supporting body tissue with same |
US9956085B2 (en) | 2005-12-23 | 2018-05-01 | DePuy Synthes Products, Inc. | Flexible elongated chain implant and method of supporting body tissue with same |
US11701233B2 (en) | 2005-12-23 | 2023-07-18 | DePuy Synthes Products, Inc. | Flexible elongated chain implant and method of supporting body tissue with same |
US11406508B2 (en) | 2005-12-23 | 2022-08-09 | DePuy Synthes Products, Inc. | Flexible elongated chain implant and method of supporting body tissue with same |
US10881520B2 (en) | 2005-12-23 | 2021-01-05 | DePuy Synthes Products, Inc. | Flexible elongated chain implant and method of supporting body tissue with same |
US20070162132A1 (en) * | 2005-12-23 | 2007-07-12 | Dominique Messerli | Flexible elongated chain implant and method of supporting body tissue with same |
US20100185290A1 (en) * | 2007-06-29 | 2010-07-22 | Curtis Compton | Flexible chain implants and instrumentation |
US9907667B2 (en) | 2007-06-29 | 2018-03-06 | DePuy Synthes Products, Inc. | Flexible chain implants and instrumentation |
US8673010B2 (en) | 2007-06-29 | 2014-03-18 | DePuy Synthes Products, LLC | Flexible chain implants and instrumentation |
US10716679B2 (en) | 2007-06-29 | 2020-07-21 | DePuy Synthes Products, Inc. | Flexible chain implants and instrumentation |
US20090248115A1 (en) * | 2008-03-26 | 2009-10-01 | Corndorf Eric D | Telemetry Control for Implantable Medical Devices |
US20090287239A1 (en) * | 2008-05-16 | 2009-11-19 | Ams Research Corporation | Tissue Bulking Device and Method |
US9943704B1 (en) * | 2009-01-21 | 2018-04-17 | Varian Medical Systems, Inc. | Method and system for fiducials contained in removable device for radiation therapy |
US20110303228A1 (en) * | 2010-06-14 | 2011-12-15 | Coloplast A/S | Incontinence treatment system |
US9023085B2 (en) | 2010-12-22 | 2015-05-05 | Walter E. Strippgen | Dynamic surgical implant |
US9393120B2 (en) | 2010-12-22 | 2016-07-19 | Walter E. Strippgen | Dynamic surgical implant |
US8231624B1 (en) * | 2010-12-22 | 2012-07-31 | Strippgen Walter E | Dynamic surgical implant |
US8608784B2 (en) | 2010-12-22 | 2013-12-17 | Walter E. Strippgen | Dynamic surgical implant |
US10485664B2 (en) * | 2015-01-09 | 2019-11-26 | Formae, Inc. | Rigid segmented flexible anchors |
US20180271659A1 (en) * | 2015-01-09 | 2018-09-27 | Formae, Inc. | Rigid segmented flexible anchors |
US11793646B2 (en) * | 2015-01-09 | 2023-10-24 | Formae, Inc. | Rigid segmented flexible anchors |
US20180289467A1 (en) * | 2017-04-05 | 2018-10-11 | Ernesto Andrade | Dispensing device, kit, and method for tissue augmentation |
WO2020077229A1 (en) * | 2018-10-11 | 2020-04-16 | Moises Jacobs | Improved gastroesophageal reflux treatment system, method, and device |
US11617586B2 (en) | 2018-10-11 | 2023-04-04 | Moises Jacobs | Gastroesophageal reflux treatment system, method, and device |
Also Published As
Publication number | Publication date |
---|---|
WO2005018468A2 (en) | 2005-03-03 |
US20100256778A1 (en) | 2010-10-07 |
WO2005018468A3 (en) | 2005-05-19 |
EP2085049A3 (en) | 2009-08-12 |
US8226730B2 (en) | 2012-07-24 |
EP2085049A2 (en) | 2009-08-05 |
JP4673305B2 (en) | 2011-04-20 |
JP2007502161A (en) | 2007-02-08 |
EP1656070B1 (en) | 2009-09-23 |
EP1656070A2 (en) | 2006-05-17 |
DE602004023302D1 (en) | 2009-11-05 |
EP2085049B1 (en) | 2019-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8226730B2 (en) | Surgical implant | |
JP2007502161A5 (en) | ||
US9301756B2 (en) | Surgical coils and methods of deploying | |
JP4805527B2 (en) | Intraluminal fundus fistula formation device | |
US7066944B2 (en) | Surgical fastening system | |
US8012140B1 (en) | Methods of transmural attachment in the gastrointestinal system | |
US7833281B2 (en) | Method and apparatus for augmentation of a sphincter | |
US6626916B1 (en) | Tissue fastening devices and methods for sustained holding strength | |
EP2217161B1 (en) | Transluminal endoscopic surgery kit | |
US20060235446A1 (en) | Article, system, and method for securing medical device to tissue or organ | |
JP7125352B2 (en) | Implant, perianal fistula treatment device, and fistula treatment system | |
JP7374129B2 (en) | Systems, devices and methods for forming anastomoses | |
US9427217B2 (en) | Apparatus and method for closing an opening in a blood vessel using memory metal and collagen | |
JP6895425B2 (en) | Reabsorbable drug-eluting submucosal implant device for turbinates | |
SK167799A3 (en) | Systems for treating fractured or diseased bone using expandable bodies | |
BR112020020005A2 (en) | SYSTEMS AND METHODS FOR ANCHORING AND RESTRICTING GASTROINTESTINAL PROSTHESES | |
US20220265262A1 (en) | Implantable Tissue Anchors, Kits That Include a Tissue Anchor, and Related Methods of Treatment | |
US20150100084A1 (en) | Devices and methods for suturing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: WILSON-COOK MEDICAL INC., NORTH CAROLINA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KENNEDY, KENNETH C., II;CHIN, LIKANG;REEL/FRAME:016210/0738;SIGNING DATES FROM 20041221 TO 20050114 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |